Congratulations Brendan (can/do), adarsh and surya!

Absurd that a 5 min email generates this level of concern! Something is deeply wrong.

Morning. Here are our guest call-ins today: - Brad Gerstner (Altimeter Capital) - AJ Piplica + Zach (Hermeus) - delian + EnduroSat (Founders Fund) Thiel Fellow lightning round (Thiel Fellowship): - Carlo Kobe (Fizz) - Steven Pang (Orbit) - Elias (Canopy Labs) -

Design is going public today. I feel immense gratitude to Evan, Figmates (past and present) and the design community. THANK YOU! cnbc.com/video/2025/07/…

It’s official. We’ve raised $14m led by OpenAI Startup Fund to bring AI to Excel. Endex is the first AI agent to live inside Excel. For the past year, we've been working with financial firms. Today we’re releasing it to the world. Our capacity is limited; comment below for

I'm excited to announce our $22M Series A here at Orchard!🍎 Here @Orchard_Robots, we’re securing America’s food supply by building the AI farmer that automates our nation’s farms. Our mission is to make farming profitable, efficient, and sustainable again.

All companies run on IT. But almost all IT teams are underwater. The ones that aren't run on Console. Console raised a $23M Series A led by DST Global Partners and Thrive Capital to help leading companies like @scale_ai, Ramp, and Webflow automate 50%+ of their tickets.

Trade On Any Exchange, Instantly As the recent rise of DEXs has shown, the future of trading in crypto is decentralized in terms of infrastructure and distribution. One platform to use them all. x.com/klyra/status/1…

AI can now predict your future — before you’re born. Nucleus Genomics just launched Origin, disease models trained on 1.5M genomes combining 7M genetic markers. Origin predicts human longevity from embryo DNA more accurately than any model ever built. And it’s open-weighted.

Today I'm excited to announce Ashlins Pharmaceuticals’ $1.2M pre-seed round, led by Mythos Ventures. We’re grateful for our investors, team, and the patient-and-physician network that believes in our mission.🚀 My first company focused on developing treatments for rare diseases.

We’ve raised our $350M Series C at a $10B valuation from Felicis, Benchmark, and General Catalyst. Just 2 years after starting, Mercor is paying $1.5 million per day to experts in our marketplace. We’re creating a new category of work in the AI economy, where software

History repeatedly shows that American science and engineering solve impossible tasks. I started Substrate because I believed that this impossible task is one worth trying.

If AI can code 100x faster, why aren't you shipping 100x faster? Because AI code is not production-ready code, and definitely not code where you understand and can vouch for every line Introducing the Command Center alpha. Support our Product Hunt launch!

the last 2 years we've been building what i always wanted to use on ethereum. this is how we it get to 3B people.

Last week the U.S. Army announced they will buy 1 million drones over the next two years- today Neros is announcing our selection for the Army’s Purpose Built Attritable System (PBAS) program and a $75M series B fundraise led by Sequoia Capital.

BREAKING Have your best baby. Today, Nucleus Genomics announces the largest genetic optimization campaign ever. > Full station-blitz of Broadway Lafayette > 1,000+ street ads across NYC > 1,000+ subway car ads > Dozens of Urban panels throughout Soho

I am excited to announce what I’ve been working on for the past 2 years. General Control is a mandate to develop programmable therapies that make durable, reversible adjustments to gene expression - epigenetically activating or silencing multiple targets at once. In the past 16